… Taylor TMaxon HRIII1998Thyrotropin suppression and disease progression in patients with
… T, Maxon HR III 1998 Thyrotropin suppression and disease progression in patients with …

… cancer (DTC) involves thyrotropin (TSH) suppression with thyroid … guidelines recommending
TSH suppression are based on … evaluating the role of TSH suppression in intermediate- and …

… TSH suppressive … suppression using sensitive TSH assays (3). However, recent findings
have largely resolved these uncertainties and confirm the beneficial effects of TSH suppressive …

… The paradigm outlined in this study could be extended to examine other types of thyroid
cancer where the biology of the disease may drive the progression of the tumor independent of …

… It thus seems that TBII are capable of suppressing TSH … ’ disease binding of TBII would also
lead to suppression of TSH … –6 months, and the duration of disease was not correlated to the …

… In conclusion, we were unable to detect a preventive effect of exogenous TSH suppression
… suppressive treatment may have a beneficial effect on thyroid enlargement in Graves' disease…

… therapy aiming at the suppression of serum thyrotropin (TSH) … of the effects of thyroid hormone
suppression therapy (THST) … adverse clinical events (disease progression/recurrence and …

… suppression … of disease progression in high-risk patients, but the data did not support the
concept that a greater degree of TSH suppression was required to prevent disease progression …

… receptor signaling is involved in the genesis of goiters, but not sufficient to induce carcinogenesis,
and thyrotropin suppression did not revert disease progression in a metastatic mouse …

… suppression and disease progression in patients with differentiated thyroid cancer:
Results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid 8:737–744. …